Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s):  CLAZF

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID... see more

TSXV:CLAS.H - Post Discussion

Claritas Pharmaceuticals Inc > Re: BZ371B For Ards !!!
View:
Post by HighSkies2019 on Oct 26, 2021 8:52pm

Re: BZ371B For Ards !!!

Not sure if you mean did I forget to mention PAH ....if so I copied this ... BZ371B inhalation reduces pulmonary arterial hypertension (PAH) .....but to be clear this says reduces ....R107 supposedly reverses ....if it's something else the floors all yours
Comment by Red~One on Oct 26, 2021 8:59pm
https://claritasinvestors.com/index.php?/articles.html/interviews/salzman-interview-16-october-2021-biozeus-deal-r163/&tab=comments#comment-183   “The drug works – at least in those patients so far, very impressive results that's number one.  Number 2, like I said, no one's ever come up with, invented, discovered, found a molecule that can turn on these particular nitric ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities